Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Optimized Icariin Cubosomes Exhibit Augmented Cytotoxicity against SKOV-3 Ovarian Cancer Cells
Usama A. Fahmy, Omar Fahmy, Nabil A. Alhakamy
Pharmaceutics (2020) Vol. 13, Iss. 1, pp. 20-20
Open Access | Times Cited: 22

Showing 22 citing articles:

Cubosomes as an emerging platform for drug delivery: a review of the state of the art
Mohammed A. S. Abourehab, Mohammad Javed Ansari, Anshul Singh, et al.
Journal of Materials Chemistry B (2022) Vol. 10, Iss. 15, pp. 2781-2819
Closed Access | Times Cited: 67
Cubosomes in cancer drug delivery: A review
Ryan Varghese, Sahil Salvi, Purab Sood, et al.
Colloids and Interface Science Communications (2021) Vol. 46, pp. 100561-100561
Open Access | Times Cited: 55
Cubosomes: Design, Development, and Tumor-Targeted Drug Delivery Applications
Hassaan Umar, Habibah A. Wahab, Amirah Mohd Gazzali, et al.
Polymers (2022) Vol. 14, Iss. 15, pp. 3118-3118
Open Access | Times Cited: 40
Inhalable bedaquiline-loaded cubosomes for the treatment of non-small cell lung cancer (NSCLC)
Suyash M. Patil, Shruti S. Sawant, Nitesh K. Kunda
International Journal of Pharmaceutics (2021) Vol. 607, pp. 121046-121046
Closed Access | Times Cited: 51
Development, Therapeutic Evaluation and Theranostic Applications of Cubosomes on Cancers: An Updated Review
Yosif Almoshari
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 600-600
Open Access | Times Cited: 30
Non-lamellar lipid liquid crystalline nanoparticles: A smart platform for nanomedicine applications
Marco Fornasier, Sergio Murgia
Frontiers in Soft Matter (2023) Vol. 3
Open Access | Times Cited: 15
Liposomes to Cubosomes: The Evolution of Lipidic Nanocarriers and Their Cutting-Edge Biomedical Applications
Nishtha Attri, Swarnali Das, Jhimli Banerjee, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 5, pp. 2677-2694
Open Access | Times Cited: 5
Correction: Fahmy et al. Optimized Icariin Cubosomes Exhibit Augmented Cytotoxicity against SKOV-3 Ovarian Cancer Cells. Pharmaceutics 2021, 13, 20
Usama A. Fahmy, Omar Fahmy, Nabil A. Alhakamy
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 145-145
Open Access
Comparative in-vitro and in-vivo evaluation of spherulites and cubosomes of Irinotecan for lung targeting
Jatin Rawat, Ravikumar Kachhadiya, Hetal Thakkar
Therapeutic Delivery (2025), pp. 1-9
Closed Access
Icariin zeinmersomes display enhanced anti-proliferative and pro-apoptotic activities in colon cancer cells
Mohammed Z. Nasrullah, Osama M. Ashour, Nabil A. Alhakamy, et al.
Future Journal of Pharmaceutical Sciences (2025) Vol. 11, Iss. 1
Open Access
Recent Advances in the Development of Liquid Crystalline Nanoparticles as Drug Delivery Systems
Jassica S. L. Leu, Jasy J. X. Teoh, Angel L. Q. Ling, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1421-1421
Open Access | Times Cited: 12
Vesicular approach of cubosomes, its components, preparation techniques, evaluation and their appraisal for targeting cancer cells
Sehrish Iqbal, Muhammad Zaman, Muhammad Ahsan Waqar, et al.
Journal of Liposome Research (2023) Vol. 34, Iss. 2, pp. 368-384
Closed Access | Times Cited: 7
Icariin attenuates the tumor growth by targeting miR-1-3p/TNKS2/Wnt/β-catenin signaling axis in ovarian cancer
Yanjin Fu, Hai‐Quan Liu, Mengsha Long, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 11
Progress and challenges of lyotropic liquid crystalline nanoparticles for innovative therapies
Ana Vitória Pupo Silvestrini, Bryan Wender Debiasi, Fabíola Silva Garcia Praça, et al.
International Journal of Pharmaceutics (2022) Vol. 628, pp. 122299-122299
Closed Access | Times Cited: 11
Liposomes to cubosomes: The evolution of lipidic nanocarriers and their cutting-edge biomedical applications
Nishtha Attri, Swarnali Das, Jhimli Banerjee, et al.
(2024)
Open Access | Times Cited: 1
Structural complexity and physical mechanism of self-assembled lipid as nanocarriers: A review
Nazhan Ilias, Rocky Vester Richmond, Gayathri Thevi Selvarajah, et al.
Asia-Pacific Journal of Molecular Biology and Biotechnology (2023), pp. 26-35
Open Access | Times Cited: 4
Zein-Stabilized Nanospheres as Nanocarriers for Boosting the Aphrodisiac Activity of Icariin: Response Surface Optimization and In Vivo Assessment
Hani Z. Asfour, Nabil A. Alhakamy, Usama A. Fahmy, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1279-1279
Open Access | Times Cited: 7
Cubosomes for enhanced drug delivery and targeting therapeutics
Hadeer M. Abdelaziz, Sarah Mokhtar, Doaa M. Anwar, et al.
Elsevier eBooks (2023), pp. 263-287
Closed Access | Times Cited: 1
Cubosomes: An Emerging and Promising Drug Delivery System for Enhancing Cancer Therapy
Smita Singh, Kapil Sachan, Suryakant Verma, et al.
Current Pharmaceutical Biotechnology (2023) Vol. 25, Iss. 6, pp. 757-771
Closed Access | Times Cited: 1
CUBOSOME-A Novel Drug Delivery for Anticancer Drugs
Ayush Dubey, Akash Chauhan, Awaneet Kaur, et al.
Current Nanoscience (2023) Vol. 20, Iss. 2, pp. 206-223
Closed Access
Cubosomes and its Pharmaceutical Application in Treatment of Cancer
Deshmukh Shradha Suresh, Anil P. Dewani, Prof A. V. Chandewar
International Journal of Advanced Research in Science Communication and Technology (2023), pp. 451-470
Open Access
Cubosome: A Potential Nanocarrier in Cancer Therapy
Jitakshara Das -, Madhuchandra Lahan, Mirza Mahmuda Yasmin -, et al.
International Journal For Multidisciplinary Research (2023) Vol. 5, Iss. 4
Open Access
Page 1

Scroll to top